Please assess the completion status of the following clinical trial:

Trial Title: 4-methylpyrazole and Acetaminophen Metabolism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy~* No APAP use in previous 2 weeks~* No ingestion of alcohol or drugs that affect CYP 2E1 over previous 5 days~* No allergy to APAP or fomepizole~* BMI \< 29~Exclusion Criteria:~* Pregnant or lactating~* History of alcohol abuse~* Allergy to APAP or fomepizole~* Screening LFTs above normal range

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- A (Type: EXPERIMENTAL): Oral APAP and IV Fomepizole.
- B (Type: ACTIVE_COMPARATOR): Oral APAP.

Based on this trial design, predict the completion outcome and termination type (if applicable).